By Michele Maatouk
Date: Wednesday 07 Jan 2026
(Sharecast News) - Ventyx Biosciences surged in pre-market trade on Wednesday following a report that Eli Lilly & Co. is in advanced talks to buy the company for more than $1bn to expand its work in immunology.
According to the Wall Street Journal, a deal for Ventyx, which specialises in developing...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news